Vaccine Supply and InnovationThe United States is facing a vaccine shortage that may threaten public health. This book examines vaccine research and development, production and supply, and utilization and offers recommendations aimed at ensuring vaccine supply and promoting innovation. In addition, this comprehensive volume provides information on the adverse reactions associated with the range of vaccines used in the United States and contains the most thorough analysis ever published on the state of the law regarding vaccine-related injury and compensation for vaccine injury. |
Contents
Summary | 1 |
Past Present and Future | 14 |
Concerns Barriers and Impediments | 27 |
Copyright | |
10 other sections not shown
Other editions - View all
Common terms and phrases
administration adverse reactions Advisory antigen antitoxin benefits Biologics caused Centers for Disease claimant committee compensation system Connaught Laboratories costs court damages decisions diphtheria Disease Control drug DTP vaccine effects established federal flu vaccine funds Guillain-Barré syndrome health belief model health care providers immunization programs individuals infectious diseases influenza Institute of Medicine issues Lederle Laboratories legislation liability licensed litigation measles mumps National no-fault insurance options payment Pediatrics percent pertussis pertussis vaccine pharmaceutical physicians plaintiff polio poliomyelitis poliovirus possible potential problems Public Health received recipients recommended reported responsible resulting risk Sharp & Dohme statute Supp supply public insurance swine flu swine flu vaccine testimony tort claims tort system U.S. Congress United vaccine commission vaccine development vaccine industry vaccine injury vaccine innovation vaccine manufacturers vaccine production vaccine supply public Vaccine-Injury Compensation vaccine-related injury virus vaccine warn Wyeth Wyeth Laboratories